Source: International Congress 2016 – Russia Session
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Alexander G. Chuchalin (Moscow, Russian Federation), Evgeny Tarabrin (Moscow, Russian Federation). Lung transplantation in idiopathic pulmonary fibrosis. International Congress 2016 – Russia Session

Member's Comments

No comment yet.

Related content which might interest you: Lung transplantation for pulmonary fibrosis Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Lung function tests and survival in idiopathic pulmonary fibrosis after lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012 Predictors of efficacy of pirfenidone in idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 4 Year: 2014 Lung transplantation for cystic fibrosis Source: Eur Respir Monogr 2014; 64: 236-245 Year: 2014 Lung transplantation for cystic fibrosis Source: International Congress 2015 – Lung transplantation in the year 2015: current indications and results Year: 2015 Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Long term efficacy of pirfenidone therapy in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 3 Year: 2014 Safety and efficacy of pirfenidone in severe idiopathic pulmonary fibrosis Source: International Congress 2014 – ILDs 3 Year: 2014 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis Source: International Congress 2016 – ILD pathogenesis Year: 2016 Changes in the small airways in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Lung transplantation for diffuse bronchiectasis Source: Annual Congress 2012 - Update on bronchiectasis Year: 2012 Proportion of idiopathic pulmonary fibrosis among interstitial lung disease in a tertiary care center and its response to treatment Source: International Congress 2014 – ILDs 5 Year: 2014 Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Role of midkine in idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014